SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-20-194428
Filing Date
2020-07-17
Accepted
2020-07-17 09:03:35
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B4 d926475d424b4.htm 424B4 2451925
2 GRAPHIC g926475g01c31.jpg GRAPHIC 84471
3 GRAPHIC g926475g02b13.jpg GRAPHIC 109709
4 GRAPHIC g926475g05p39.jpg GRAPHIC 52767
5 GRAPHIC g926475g10p16.jpg GRAPHIC 117070
6 GRAPHIC g926475g13g31.jpg GRAPHIC 54504
7 GRAPHIC g926475g22k40.jpg GRAPHIC 72611
8 GRAPHIC g926475g25e15.jpg GRAPHIC 64261
9 GRAPHIC g926475g35p85.jpg GRAPHIC 104400
10 GRAPHIC g926475g48f16.jpg GRAPHIC 37472
11 GRAPHIC g926475g54n63.jpg GRAPHIC 47998
12 GRAPHIC g926475g66x45.jpg GRAPHIC 57274
13 GRAPHIC g926475g71q89.jpg GRAPHIC 124162
14 GRAPHIC g926475g76b54.jpg GRAPHIC 47251
15 GRAPHIC g926475g78n61.jpg GRAPHIC 64549
16 GRAPHIC g926475g85k46.jpg GRAPHIC 147015
17 GRAPHIC g926475g97o35.jpg GRAPHIC 53590
  Complete submission text file 0001193125-20-194428.txt   4127690
Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Filer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-239500 | Film No.: 201032844
SIC: 2834 Pharmaceutical Preparations